Laura Sepp-Lorenzino's Net Worth
$19.2 Million
Who is Laura Sepp-Lorenzino?
Laura Sepp-Lorenzino has an estimated net worth of $19.2 Million. This is based on reported shares across multiple companies, which include Intellia Therapeutics, Inc., and Taysha Gene Therapies, Inc..
SEC CIK
Laura Sepp-Lorenzino's CIK is 0001777421
Past Insider Trading and Trends
2021 was Laura Sepp-Lorenzino's most active year for acquiring shares with 6 total transactions. Laura Sepp-Lorenzino's most active month to acquire stocks was the month of February. 2021 was Laura Sepp-Lorenzino's most active year for disposing of shares, totalling 19 transactions. Laura Sepp-Lorenzino's most active month to dispose stocks was the month of July. 2021 saw Laura Sepp-Lorenzino paying a total of $1,707,700.00 for 236,500 shares, this is the most they've acquired in one year. In 2021 Laura Sepp-Lorenzino cashed out on 246,000 shares for a total of $18,612,411.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
EVP, Chief Scientific OfficerLaura Sepp-Lorenzino owns 81,893 units of Common Stock which is worth $1,617,386.75. From 2019 to 2024 Laura Sepp-Lorenzino acquired a total of 215,220 shares in Intellia Therapeutics, Inc. at a cost of $1,707,700.00, Laura also disposed a total of 136,793 shares of Intellia Therapeutics, Inc. equalling to $19,152,910.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.43% | 37.97K |
—
|
—
| 81.89K |
Mar 1
| |||
Form 4
| -4.92% | -2.27K |
$28.87 | -$65,681.74 | 43.93K |
Jan 8
| |||
Form 4
| -10.69% | -5.53K |
$29.46 | -$162,972.72 | 46.2K |
Jan 3
| |||
Form 4
| +7.26% | 3.5K |
—
|
—
| 51.73K |
Jan 1
| |||
Form 4
| +169.82% | 29.94K |
—
|
—
| 47.57K |
Mar 1
| |||
Form 4
| -21.53% | -4.84K |
$37.82 | -$182,981.60 | 17.63K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| +18.45% | 3.5K |
—
|
—
| 22.47K |
Jan 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +656.44% | 16.17K |
$112.25 | -$128,863.00 | 18.63K |
Jan 1 - Mar 1
| |||
Form 4
|
—
|
0
|
$84.42 | -$13,658,754.43 | 2.39K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$75.82 | -$3,245,956.93 | 2.39K |
Scheduled
|
Aug 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $2.09
InvestorLaura Sepp-Lorenzino owns 49,220 units of Common Stock which is worth $102,869.80. From 2020 to 2024 Laura Sepp-Lorenzino acquired a total of 49,220 shares in Taysha Gene Therapies, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 49.22K |
—
|
—
| 49.22K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||